2015
DOI: 10.2337/dc14-2552
|View full text |Cite
|
Sign up to set email alerts
|

Response to Comment on Stegman et al. High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 2014;37:3114–3120

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2016
2016

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Since mevalonic acid, the end product of said enzymatic reaction, is one of the foundational baseline substances to various isoprenoid metabolites [1,3], it could potentially lead to pleiotrophic effects of the aforementioned drugs. Also, growing evidence reveals that some other beneficial influence of these agents may have a significant effect on lowering plasma cholesterol levels [4][5][6][7][8]. As it appears, the positive effect surpasses the cholesterollowering result of statins through its protective effects on atherosclerotic plague stabilization and endothelial nitric oxide bioactivity [9,10].…”
Section: Introductionmentioning
confidence: 94%
“…Since mevalonic acid, the end product of said enzymatic reaction, is one of the foundational baseline substances to various isoprenoid metabolites [1,3], it could potentially lead to pleiotrophic effects of the aforementioned drugs. Also, growing evidence reveals that some other beneficial influence of these agents may have a significant effect on lowering plasma cholesterol levels [4][5][6][7][8]. As it appears, the positive effect surpasses the cholesterollowering result of statins through its protective effects on atherosclerotic plague stabilization and endothelial nitric oxide bioactivity [9,10].…”
Section: Introductionmentioning
confidence: 94%